An Unhealthy America: The Economic Burden of Chronic Disease

Similar documents
An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

An Unhealthy America:

Living standards. institute view

Expenditure Share United States, 2003

An Unhe althy Americ a: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

Effective Technology and Its Economic Benefits: The Case of Colonoscopy

National health-care expenditures are projected to rise to $5.2 trillion by 2023

PREVENTION FOR A HEALTHIER AMERICA: Investments in Disease Prevention Yield Significant Savings, Stronger Communities

THE PERRYMAN GROUP. 510 N. Valley Mills Dr., Suite 300. Waco, TX ph , fax

Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Please note, this report is designed for double-sided printing

The Wellbeing of America s Workforce, and Its Effects on an Organization s Performance

The clinical and economic benefits of better treatment of adult Medicaid beneficiaries with diabetes

The cost of the double burden of malnutrition. April Economic Commission for Latin America and the Caribbean

Childhood Obesity in North Carolina: Economic Cost and Implications

CHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO

Meltdown : Investing in Prevention. October 7, 2008

Peter Attia had just become the first person to swim from Maui to Lanai and back (a 25-mile round trip). Age: 35 Weight: 200 lbs.

THE HEALTH AND ECONOMIC THREATS OF NON-COMMUNICABLE DISEASES IN THE MIDDLE EAST AND NORTH AFRICA, CV BoD in Egypt/ MENA

Appendix C CHANGING THE TRAJECTORY:

IF WE DON T FOCUS ON PREVENTING CHRONIC DISEASE, WE RE ONLY TINKERING AT THE EDGES

2012 Medicaid and Partnership Chart

STATE RANKINGS REPORT NOVEMBER mississippi tobacco data

July 2014 HEALTHY SAVINGS. Medical Technology and the Economic Burden of Disease. Anusuya Chatterjee, Jaque King, Sindhu Kubendran, and Ross DeVol

CHECKUP TIME Chronic Disease and Wellness in America

The State of Obesity 2017 Better Policies for a Healthier America

The Healthy Indiana Plan

Better Health Care. Millions of People. Hypertension 26% Arthritis 20% Respiratory Diseases 19% Cholesterol Disorders 13%

7/29/2010. Sharon Moffatt RN BSN MSN Chief of Health Promotion Association of State and Territorial Health July 25, 2010.

MetLife Foundation Alzheimer's Survey: What America Thinks

State Health Reform. Part 2. By Laura Tobler Program Director, Health Program National Conference of State Legislatures

Tobacco Health Cost in Egypt

Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers

A COMPREHENSIVE REPORT ISSUED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS IN PARTNERSHIP WITH:

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both

Opioid Deaths Quadruple Since 1999

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

IMPACT OF DEVELOPMENT ASSISTANCE FOR HEALTH ON COUNTRY SPENDING

Heart Disease and Stroke in New Mexico. Facts and Figures: At-A-Glance

The Cost of Diabetes in PRINCE EDWARD ISLAND

Merkin Brain and Health Policy Innovation Program 2013

The Cost of Diabetes in NEWFOUNDLAND & LABRADOR

TOBACCO CONTROL ECONOMICS TOBACCO FREE INITIATIVE PREVENTION OF NONCOMMUNICABLE DISEASES

650, Our Failure to Deliver

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Obesity: Trends, Impact, Complexity

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Healthcare expenditure and productivity cost savings resulting from increased intake of grain fibre in Australia.

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.

SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS

Public Health Federal Funding Request to Address the Opioid Epidemic

Behavioral Health: Public Health Challenge Public Health Opportunity. Pamela S. Hyde, J.D. SAMHSA Administrator

The Cost of Diabetes in MANITOBA

Why Preventing Chronic Disease is Essential - Prevention Works

Public Health and the Promise of Prevention

5 $3 billion per disease

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

AIDS Funding Landscape in Asia and the Pacific

Evaluations. Dementia Update: A New National Plan for Alzheimer s Disease Research, Care and Services. Disclosure Statements.

Michigan Nutrition Network Outcomes: Balance caloric intake from food and beverages with caloric expenditure.

Why Non communicable Diseases? Why now?

PROVATA HEALTH. Proven Science. Proven Results.

Executive Summary. Overall conclusions of this report include:

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

Tobacco Control Policy at the State Level. Progress and Challenges. Danny McGoldrick Institute of Medicine Washington, DC June 11, 2012

Common Questions about Cancer

Merkin Brain and Health Policy Innovation Program 2013

The Burden of Cardiovascular Disease in North Carolina June 2009 Update

The Cost of Diabetes in NOVA SCOTIA

Inflation projection of the National Bank of Poland based on the NECMOD model

Health Disparities Matter!

The impact of pharmaceutical innovation on New Zealand cancer patients

Health Strategies for NCD prevention and Control

Data for Healthy Insights

National Dental Expenditure Flat Since 2008, Began to Slow in 2002

The impact of pharmaceutical innovation on longevity, quality of life, and medical expenditure

SUPPORT FEDERAL FUNDING FOR PARKINSON S DISEASE RESEARCH AND DRUG DEVELOPMENT

ARE STATES DELIVERING?

Evaluating the Economic Consequences of Avian Influenza (1) Andrew Burns, Dominique van der Mensbrugghe, Hans Timmer (2)

Behavioral Health: Public Health Challenge Public Health Opportunity. Pamela S. Hyde, J.D. SAMHSA Administrator

October 3, Dear Representative Hensarling:

Pandemic Flu Impact in U.S.

Prioritizing Disease Prevention. Man and women, young and old, black and white, gay and straight, rich and poor,

Insurance Providers Reduce Diabetes Risk Through CDC Program

Easing the Burden of Noncommunicable Disease

Oklahoma Turning Point Council (OTPC)

Responses to a 2017 Survey on State Policies Regarding Community Health Workers: Home Visiting to Improve the Home Environment

ANNUAL REPORT DECEMBER The full report is available at

CANADIAN DIABETES ASSOCIATION

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment

Cessation and Cessation Measures

Morehouse College January 2010 Health and Wellness Topic

Submission to Standing Committee on Health. With no leadership, Canada s diabetes crisis will continue to get worse

The Challenge of Accelerating Medical Solutions Through Philanthropy. Steve Case, Case Foundation Mike Milken, FasterCures

OBESITY IN MISSOURI: IMPLICATIONS FOR HEALTH / FOOD POLICY

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:

THE COST OF DIABETES IN ALBERTA

Youth and Adult Marijuana Use

Chronic Disease Challenges and Solutions

Transcription:

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth February 2008

Today s Presentation General trends in chronic disease in the U.S. Findings from the Milken study 2

Example of Rising Prevalence of Disease: Diabetes, 1994 and 2004 The prevalence of diabetes increased in nearly every state between 1994 and 2004 1994 2004 Source: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Adult and Community Health, data from the Behavioral Risk Factor Surveillance System. Data computed by the Division of Diabetes Translation. Available at http://www.cdc.gov/diabetes/statistics/prev/state/fprev1994and2004.htm 3

Disease Prevalence and Health Care Costs More than 75 percent of the rise in costs for three common conditions can be explained by increases in treated prevalence and population growth Percent Change in Spending Due to Rise in Treated Prevalence and Increased Population, 1987-2000 Discussion of the magnitude of health care spending growth usually does not take into account changes in disease prevalence and demographic factors behind spending growth. -- Kenneth Thorpe, Emory University Percent Increase Due to Rise in Treated Prevalence and Increased Population 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 79% 79% Mental Disorders Cerebrovascular Disease 76% Diabetes Source: Thorpe et. al., Which Medical Conditions Account for the Rise in Health Care Spending, Health Affairs, 25 August 2004. 4

U.S. Health Care Spending for Patients with Chronic Conditions 65 percent of all health care spending goes to treat patients with 2 or more chronic conditions 100% 80% 60% 14% 12% 23% 47% 40% 18% 20% 0% 51% Population 20% 15% Health Care Expenditures 0 Conditions 1 Condition 2 Conditons 3 or More Conditions Source: Gerard Anderson, analysis, prepared for PhRMA, of the Medical Expenditure Panel Survey, 2004. 5

Per Capita Health Spending for Patients with Chronic Conditions Annual spending for individuals with two chronic conditions is more than 5 times greater than for those without any condition Spending is almost 17 times higher for individuals with five or more chronic diseases, compared to spending for those without any condition. $20,000 $18,000 $16,000 $14,000 $12,000 $10,000 $8,000 $6,000 $4,000 $2,000 $0 Average Yearly Per Capita Health Care Spending for Persons with Chronic Diseases $994 $2,753 Source: Gerard Anderson, analysis of the Medical Expenditure Panel Survey, 2004. $5,026 $7,381 $10,091 $16,819 0 1 2 3 4 5+ Number of Chronic Conditions 6

Projected Rates of Chronic Disease Through 2030, the number of Americans with a chronic disease is expected to increase by more than 1 percent every year 180 160 140 120 100 Number of People with Chronic Diseases (millions) 171 164 157 149 141 133 125 118 1995 2000 2005 2010 2015 2020 2025 2030 Year Chronic illness is a major health challenge The aging of the U.S. population and increases in risk factors such as obesity suggest that chronic illnesses will be an even greater problem in future years. - Homer, Hirsch, and Milstein Sources: Wu, Shin-Yi and Green, Anthony. Projection of Chronic Illness Prevalence and Cost Inflation. Rand Corporation, October 2000; J. Homer, G. Hirsch, and B. Milstein. Chronic Illness in a Complex Health Economy: The Perils and Promises of Downstream and Upstream Reforms. Systems Dynamics Review, Oct 30 2007. Vol. 23, No.2-3, pgs.313-343. 7

Highlights from Milken Institute Report: An Unhealthy America: The Economic Burden of Chronic Disease 8

The Economic Burden of Chronic Disease: Two Paths, Two Choices Chronic Disease Today: The Current Toll The Human Cost The Economic Cost Chronic Disease Tomorrow: The Future Toll The Future on Our Current Path The Alternative Path: Cases and costs avoidable with reasonable action Longer Term Impact on GDP growth Conclusion and Recommendations 9

The Economic Burden of Chronic Disease: Two Paths, Two Choices Chronic Disease Today: The Current Toll The Human Cost The Economic Cost Chronic Disease Tomorrow: The Future Toll The Future on Our Current Path The Alternative Path: Cases and costs avoidable with reasonable action Longer Term Impact on GDP growth Conclusion and Recommendations 10

The Human Cost: Millions of Americans Have a Chronic Disease Number Reporting Seven Common Chronic Disease, 2003 United States Pulmonary conditions 49.2 Hypertension 36.8 Mental Disorders 30.3 Heart Disease 19.1 Diabetes Cancers 10.6 13.7 Stroke 2.4 0 10 20 30 40 50 60 Population Reporting Condition (Millions) Total: 109 Million Americans; 162 Million Cases 11

The Human Cost: Millions of Americans Have a Chronic Disease Number Reporting Seven Common Chronic Disease, 2003 California Pulmonary conditions 5,301 Hypertension 3,660 Mental Disorders 2,534 Heart Disease Diabetes Cancers 1,155 1,860 1,573 Stroke 241 0 1000 2000 3000 4000 5000 6000 Population Reporting Condition (Millions) Total: 109 Million Americans; 162 Million Cases 12

The Human Cost: The Burden of Chronic Disease Varies by State The Milken State Chronic Disease Index States in Top Quartile have the Lowest Rates of Seven Common Chronic Diseases Top Quartile Second Third Bottom Quartile States with Highest Rates of Chronic Disease: 1. West Virginia 2. Tennessee 3. Arkansas 4. Kentucky 5. Mississippi 6. Pennsylvania 7. Rhode Island 8. Maine 9. Oklahoma 10. Alabama 13

The Economic Cost: Chronic Diseases Account for Billions in Health Care Spending & Lost Output Economic Impact of Chronic Disease, 2003 United States Cancers Hypertension $48 $33 $271 $280 Mental Disorders Heart Disease $46 $65 $105 $171 Pulmonary Conditions Diabetes $27 $45 $105 $94 Total Treatment Expenditures = $277B Total Lost Economic Output = $1,047B Stroke $14 $22 $- $50 $100 $150 $200 $250 $300 $350 Billions 14

Sources of Lost Productivity Absenteeism Presenteeism 15

The Economic Cost: Lost Productivity From Chronic Disease Costs Our Economy Billions Each Year Lost Workdays Individual $127.5 Lost Productivity by Source, 2003 (in US$ Billions) Presenteeism Caregiver $80.2 Presenteeism Individual $828.2 Lost Workdays Caregiver $10.8 Total Lost Productivity in 2003 = $1.0 Trillion in U.S., and $106 Billion in California Alone 16

The Economic Burden of Chronic Disease: Two Paths, Two Choices Chronic Disease Today: The Current Toll The Human Cost The Economic Cost Chronic Disease Tomorrow: The Future Toll The Future on Our Current Path The Alternative Future: Cases and costs avoidable with reasonable action Longer Term Impact on GDP growth Conclusion and Recommendations 17

Chronic Disease Rates Are Expected to Grow Dramatically Expected Growth in Prevalence of Major Chronic Conditions 2003 to 2023 70% 62% 60% 53% 54% 50% 40% 30% 31% 39% 41% 29% 20% Population Growth = 19% 10% 0% Cancers Pulmonary Conditions Diabetes Hypertension Heart Disease Stroke Mental Disorders 18

Our Current Path: Chronic Disease Will Cost U.S. Economy Over $4 Trillion Annually by 2023 Total Economic Costs (US$ Billions) 4500 4000 3500 3000 2500 2000 1500 1000 500 Current Path: Combined Value of Treatment Expenditures and Productivity Losses in U.S. Lost Economic Output Treatment Expenditures For California, cost is over $430 billion annually by 2023 -- $360 in lost productivity and over $70 billion in treatment expenditures annually 0 2003 2005 2007 2009 2011 2013 2015 2017 2019 2021 2023 19

The Alternative Path: Improvements in Prevention, Behavior, and Treatment Cases and Treatment Costs Under Alternative Path The Assumptions: From 2003 to 2023, we assume reasonable improvements, such as: A reduction in number of obese persons (to 1998 levels of 19%) A continued reduction in smoking to 15% A decline in at risk drinking (from 6% to 4%) An increase in physical activity (from 75% to 83%) A decrease in high cholesterol levels (to 2000 levels of 32%) An improvement in air quality A gradual decline in illicit drug use A modest improvement in early intervention and treatment Lower health care cost growth 20

The Alternative Path: We Could Reduce Chronic Disease Rates Dramatically Improvements in the prevention and management of chronic disease could avoid over 40 million cases of seven common chronic conditions in 2023 Mental Disorders Stroke -0.6-5.8 On Current Path Heart Disease -9.4 With Reasonable Increase in Prevention Efforts Hypertension Diabetes -2.8-9.6 Pulmonary Condtions Cancers -3.1-9.1 0 20 40 60 80 Reported Cases (Millions) Source: Devol, Ross and Armen Bedroussian, An Unhealthy America: Economic Burden of Chronic Disease. Milken Institute, October 2007. 21

The Alternative Path: And Reduce Economic Costs in 2023 by $1.1 Trillion Projected Annual Economic Costs 2003 2023 (Billions) United States $4,500 $4,000 $3,500 $3,000 $2,500 $2,000 $1,500 $1,000 $500 $0 $1,123 $297 $3,030 $2,192 $1,324 2003 2013 2023 Improvements in prevention and early detection could reduce economic costs of chronic disease by $1.1 trillion in 2023: $905 billion from gains in productivity $218 billion from avoided treatment expenditures 22

The Alternative Path: And Reduce Economic Costs in 2023 by $1.1 Trillion Projected Annual Economic Costs 2003 2023 (Billions) California $500 $450 $400 $350 $300 $250 $200 $150 $100 $50 $0 $117 $30 $314 $224 $133 2003 2013 2023 Improvements in prevention and early detection could reduce economic costs of chronic disease in California by $117 billion in 2023: $98 billion from gains in productivity $19 billion from avoided treatment expenditures 23

For Example, Lower Obesity Rates Would Avoid Over $800 Billion in Economic Costs in the Year 2023 Avoidable Economic Costs Attributable to Decline in Obesity Projected Estimates, 2023 Cancers $73 $312 Heart Disease $73 $118 Obesity Other Factors Hypertension $100 $87 Diabetes $52 $39 $0 $100 $200 $300 $400 $500 Avoidable Economic Impact (Billions) 24

Longer term impact: Chronic Disease Prevention & Management Can Accelerate GDP Growth US$ Trillions 6 5 4 3 2 1 0 Long-Term Forgone Economic Output Change in Real GDP Between Baseline and Optimistic Scenarios 2005 2010 2015 2020 2025 2030 2035 2040 2045 2050 WHY IS THIS? Healthy Americans are more productive Americans Healthy Americans are able to get higher levels of education The higher an income earner s human capital, the greater the probability of investment in their children s and grandchildren's education Year On this alternative path, U.S. GDP could increase by as much $5.7 Trillion Annually by 2050 25

Longer term impact: Chronic Disease Prevention & Management Can Accelerate GDP Growth California s Gross Domestic Product in 2050* Current versus Alternative Path GDP in 2050, Current Path GDP in 2050, Alternative Path Potential Real Gain in GDP $5,188 Billion $6,096 Billion $908 Billion *Inflation adjusted (2003 dollars) If Californian s take action today, California s annual GDP can be increased by as much as 18 percent, or $908 Billion, by 2050 26

Economic Burden of Chronic Disease: Conclusions and Recommendations Conclusions: Lost Productivity Surpasses Treatment as the Cause of Economic Burden Early Interventions and Medical Innovations Improve Quality and Longevity of Life Good Health Is an Investment in Economic Growth Recommendations from Milken Institute: Incentives for Prevention and Early Intervention We need private-public partnerships to incentivize patients and providers to prevent chronic disease effectively Healthy Body Weight Initiative We need a strong, long-term national commitment to promote health, wellness, and healthy body weight 27